Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Squamous cell carcinoma of oropharynx
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
155
|
33
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Congenital neutropenia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Congenital Abnormality
|
68
|
11
|
0.010 |
None |
< 0.001 |
1 |
|
2003 |
2003 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Epithelial ovarian cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
1224
|
129
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Compound leukemias
|
disease |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult T Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
102
|
1
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
stage, non-small cell lung cancer
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
107
|
6
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Childhood T Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
119
|
2
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
491
|
20
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult Non-Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
370
|
39
|
0.010 |
None |
1.000 |
1 |
|
1989 |
1989 |
Childhood Non-Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
371
|
39
|
0.010 |
None |
1.000 |
1 |
|
1989 |
1989 |
Adult Acute Myeloblastic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
160
|
3
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Mastocytosis, Systemic
|
disease |
Neoplasms; Immune System Diseases
|
Neoplastic Process
|
94
|
11
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cerebral atrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
454
|
44
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Neoplasm, Residual
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
329
|
23
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |